Bilcare: The Board of Directors of Bilcare Limited in their meeting held on Tuesday, 03 November 2026 have approved…
Bilcare (BI) filed a disclosure titled "The Board of Directors of Bilcare Limited in their meeting held on Tuesday, 03 November 2026 have approved and taken on record Standalone and Consolidated Unaudited Financial…". The company is valued at about ₹186 crore.
What happened
Bilcare (BI) filed a disclosure with the exchanges on 3 November 2026 at 09:38 PM titled "The Board of Directors of Bilcare Limited in their meeting held on Tuesday, 03 November 2026 have approved and taken on record Standalone and Consolidated Unaudited Financial…".
Company snapshot
Bilcare is a micro-cap company, with a market value of about ₹186 crore.
The stock last traded at ₹79.17, against a 52-week range of ₹51.62–₹113 (29.9% below the high).
Before this filing the shares had moved −19.9% over the month and +34.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.08 crore.
Promoters held 30.01% at the end of Q1 FY27; 1.39% of promoter shares were pledged. Foreign institutions owned 0.04% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 2 | 3.6 | 1.52 |
| Q2 FY26 | 2 | 1 | 0.44 |
| Q3 FY26 | 2 | 2.7 | 1.15 |
| Q4 FY26 | 1 | -6.4 | -2.7 |
| Q1 FY27 | 2 | 1 | 0.44 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.